Furthermore, for a more advanced model, which may even evaluate the severity and risk factor of the ICAS without the need to image based data, Interleukin-6 and Lipoprotein-associated phospholipase A2 would allow the model a deeper understanding of ICAS and the causes of stroke [30, 31]. This evidence concerns the gene IL6 and familial isolated congenital asplenia.